Search Results 1-10 of 16463 for immunothérapie vitiligo effets secondaires psychiatriques

  1. Vitiligo - Diagnosis & treatment - Mayo Clinic

    Medications and light-based therapies are available to help restore skin color or even out skin tone, though results vary and are unpredictable. And some ...

  2. Vitiligo - Symptoms & causes - Mayo Clinic

    Learn more about this condition in which your skin loses pigment cells, resulting in very light or white patches on parts of the body.

  3. Untitled

    Page 1.

  4. Vitiligo - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  5. https://www.mayoclinic.org/chinese_condition_consolidated_concepts.xml

  6. Breast cancer treatment Archives - Mayo Clinic News Network

    chemotherapy, which I've traditionally heard about for treating cancer? ANSWER: Immunotherapy is a newer therapy in the current treatment landscape for breast ...

  7. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

    Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

  8. Clinical trials - Oncology (Medical)

    Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ...

  9. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  10. A Study to Evaluate Mutanome-directed Immunotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

    The purpose of this study is to evaluate the safety and tolerability of multiple subcutaneous injections of a mutanome-directed active immunotherapy (TG4050) in ...